Belgium, Jan. 2 -- Belgium based Fresenius Kabi has secured contract from Centrale de Negociation pour les Achats Hospitaliers for Pharmaceutical products - Framework agreement for the supply of Ceftriaxone. The value of the contract is worth 38408400 EUR.
Published by HT Digital Content Services with permission from Pivotal Sources....